A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas

NCT02220855 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Thymoma

Interventions

DRUG: BKM120

Sponsor

Patrick Joseph Loehrer Sr.

Collaborators

[object Object]